Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 18, 2021
EQRx, and Evotec SE announced a collaboration to design, discover and develop new therapeutic options for patients. The collaboration will help accelerate EQRx’s pipeline expansion efforts by leveraging Evotec’s unique data-driven, fully integrated R...
read more
Eremid Research Services has been established as the new name for the commercial arm of the 501(c)(3) non-profit, research organization - DHMRI.
read more
Monday, December 21, 2020
Ergomed has announced the acquisition of MS Clinical Services, a specialized CRO based in Houston, Texas.
read more
ERS Genomics Limited announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS’ CRISPR/Cas9 patent portfolio.
read more
CRISPR offerings to enhance NUVISAN’s drug development service portfolio.
read more
ERS Genomics has announced the signing of a license agreement with Otsuka Pharmaceutical.
read more
Monday, September 21, 2020
ERS Genomics has signed an agreement with Applied StemCell, a provider of stem cell, animal model, antibody discovery services and reagents.
read more
ERS Genomics announced the signing of a license agreement granting Axxam access to ERS Genomics' CRISPR-Cas9 patent portfolio, to support Axxam's integrated discovery service platform.
read more
Friday, November 10, 2017
ERS Genomics and Cellecta announced a non-exclusive license agreement to provide Cellecta worldwide access to ERS Genomics' CRISPR/Cas9 genome editing intellectual.
read more
Thursday, February 25, 2021
ERS Genomics has announced a non-exclusive license agreement granting G+FLAS access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
Thursday, February 18, 2021
ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
read more
ERT has announced the acquisition of APDM Wearable Technologies, a next-generation provider of wearables and digital biomarkers.
read more
Monday, September 11, 2017
ERT announced it has acquired Biomedical Systems, a well-recognized provider of reliable imaging, as well as cardiac safety and respiratory data collection solutions.
read more
Monday, December 19, 2016
ERT, a l provider of high-quality patient data collection solutions for use in clinical drug development, has announced the acquisition of Exco InTouch, a provider of patient engagement, data capture and digital health solutions. The combined ...
read more
Monday, December 04, 2017
ERT has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory solutions that accelerate clinical research.
read more